Literature DB >> 29086020

AR-V7 predicting treatment response in metastasized prostate cancer: has it peaked?

Igor Tsaur1, Hendrik Borgmann2, Christian I Surcel3, Piet Ost4, Guillaume Ploussard5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29086020     DOI： 10.1007/s00345-017-2107-4

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  5 in total

1.  Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer.

Authors:  Howard I Scher; Ryon P Graf; Nicole A Schreiber; Brigit McLaughlin; David Lu; Jessica Louw; Daniel C Danila; Lyndsey Dugan; Ann Johnson; Glenn Heller; Martin Fleisher; Ryan Dittamore
Journal:  Eur Urol       Date:  2016-12-12       Impact factor: 20.096

2.  Commentary on "AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer." Antonarakis ES, Lu C, Wang H, Luber B, Nakazawa M, Roeser JC, Chen Y, Mohammad TA, Chen Y, Fedor HL, Lotan TL, Zheng Q, De Marzo AM, Isaacs JT, Isaacs WB, Nadal R, Paller CJ, Denmeade SR, Carducci MA, Eisenberger MA, Luo J, Division of Urologic Oncology, Department of Urology, University of Michigan, MI. N Engl J Med 2014; 371(11):1028-38.

Authors:  Ganesh S Palapattu
Journal:  Urol Oncol       Date:  2016-03-07       Impact factor: 3.498

3.  Association of AR-V7 and Prostate-Specific Antigen RNA Levels in Blood with Efficacy of Abiraterone Acetate and Enzalutamide Treatment in Men with Prostate Cancer.

Authors:  Fangfang Qu; Wanling Xie; Mari Nakabayashi; Haitao Zhang; Seong Ho Jeong; Xiaodong Wang; Kazumasa Komura; Christopher J Sweeney; Oliver Sartor; Gwo-Shu Mary Lee; Philip W Kantoff
Journal:  Clin Cancer Res       Date:  2016-08-03       Impact factor: 12.531

4.  Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer.

Authors:  Christof Bernemann; Thomas J Schnoeller; Manuel Luedeke; Konrad Steinestel; Martin Boegemann; Andres J Schrader; Julie Steinestel
Journal:  Eur Urol       Date:  2016-07-26       Impact factor: 20.096

5.  Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer.

Authors:  Emmanuel S Antonarakis; Changxue Lu; Brandon Luber; Hao Wang; Yan Chen; Mary Nakazawa; Rosa Nadal; Channing J Paller; Samuel R Denmeade; Michael A Carducci; Mario A Eisenberger; Jun Luo
Journal:  JAMA Oncol       Date:  2015-08       Impact factor: 31.777
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.